OpenVSafe by OpenVAERS
Search V-safe

YN4-29289-72018

2 vaccinations 2 coded responses 2 check-ins 2 free-text entries 1 call case
Sex
Female
Age at first dose
36-40
ZIP prefix
662 / KS
Registered
2021-04-10
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino
Registered dependents
SCW-90155-46236 Child or adolescent in my care · Female · 2022-06-27
NVH-19329-57977 Child or adolescent in my care · Male · 2022-07-13

Timeline

  1. 2021-03-04
    Dose 1 — Pfizer-BioNTech
  2. 2021-03-25
    Dose 2 — Pfizer-BioNTech
  3. 2021-04-10
    Registered in v-safe
  4. 2021-04-10
    Survey response — day 14, dose 2
    MedDRA: Anxiety — Feeling: Good · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: Increased anxiety
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-04-10
    Report sent to call center — day 14, dose 2
    Get care from a doctor or other healthcare professional
    1 call case(s)
  6. 2021-09-23
    Survey response — 6 months, dose 2
    MedDRA: Pregnancy — Feeling: Good
    Free text: Pregnant
    MedDRA releases: 2024-11 · check-in free text available
  7. 2022-02-21

Vaccinations

DoseDateManufacturerCo-administered
12021-03-04Pfizer-BioNTech
22021-03-25Pfizer-BioNTech

Call center

ReportedOutcomeVAERS-related outcome
2021-04-10 Unsuccessful

Free text

Release 7 — day 14, dose 2

2021-04-10

Symptoms: Increased anxiety

Release 9 — 6 months, dose 2

2021-09-23

Symptoms: Pregnant

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAnxiety ✓ ✓ ✓
SDPregnancy · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release